Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Dec 15 2023
Business
Dec 15 2023
4 min read

Press Release Dec 15 2023

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 15, 2023, titled "Zydus receives final approval from the USFDA for Darunavir Tablets 600 mg and 800 mg, and tentative approval for 75 mg and 150 mg tablets".

View Attachment